Peter J Mariani Axogen, Inc. (AXGN) insider trading activity

Peter J Mariani is EVP & Chief Financial Officer of Axogen, Inc.. Currently has a direct ownership of 63,603 shares of AXGN, which is worth approximately $1.03 Million. The most recent transaction as insider was on Dec 11, 2023, when has been sold 12,500 shares (Common Stock) at a price of $7.51 per share, resulting in proceeds of $93,875. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 63.6K

0% 3M change

0% 12M change

Total Value Held $1.03 Million

PETER J MARIANI Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 11 2023	SELL Open market or private sale	$93,875 $7.51 p/Share	12,500 Reduced 16.43%	63,603 Common Stock
Oct 13 2023	SELL Sale (or disposition) back to the issuer	$13,182 $4.04 p/Share	3,263 Reduced 4.11%	76,103 Common Stock
Jul 18 2023	BUY Grant, award, or other acquisition	-	3,709 Added 4.46%	79,366 Common Stock
Mar 16 2023	SELL Payment of exercise price or tax liability	$58,204 $8.27 p/Share	7,038 Reduced 8.51%	75,657 Common Stock
Mar 16 2023	BUY Exercise of conversion of derivative security	-	20,750 Added 20.43%	80,829 Common Stock
Feb 01 2023	SELL Open market or private sale	$136,188 $9.36 p/Share	14,550 Reduced 19.02%	61,945 Common Stock
Feb 01 2023	BUY Exercise of conversion of derivative security	$105,537 $5.04 p/Share	20,940 Added 21.49%	76,495 Common Stock
Jan 31 2023	SELL Open market or private sale	$136,756 $9.55 p/Share	14,320 Reduced 20.49%	55,555 Common Stock
Jan 31 2023	BUY Exercise of conversion of derivative security	$105,532 $5.04 p/Share	20,939 Added 23.06%	69,875 Common Stock
Jan 30 2023	SELL Open market or private sale	$136,735 $9.69 p/Share	14,111 Reduced 22.38%	48,936 Common Stock
Jan 30 2023	BUY Exercise of conversion of derivative security	$105,532 $5.04 p/Share	20,939 Added 24.93%	63,047 Common Stock
Jan 27 2023	SELL Open market or private sale	$212,750 $10.16 p/Share	20,940 Reduced 33.21%	42,108 Common Stock
Jan 27 2023	BUY Exercise of conversion of derivative security	$105,537 $5.04 p/Share	20,940 Added 24.93%	63,048 Common Stock
Jan 26 2023	SELL Open market or private sale	$207,296 $9.9 p/Share	20,939 Reduced 33.21%	42,108 Common Stock
Jan 26 2023	BUY Exercise of conversion of derivative security	$105,532 $5.04 p/Share	20,939 Added 24.93%	63,047 Common Stock
Jan 25 2023	SELL Open market or private sale	$214,205 $10.23 p/Share	20,939 Reduced 33.21%	42,108 Common Stock
Jan 25 2023	BUY Exercise of conversion of derivative security	$105,532 $5.04 p/Share	20,939 Added 24.93%	63,047 Common Stock
Dec 27 2022	SELL Payment of exercise price or tax liability	$6,126 $9.44 p/Share	649 Reduced 1.52%	42,108 Common Stock
Dec 27 2022	BUY Exercise of conversion of derivative security	-	2,625 Added 5.78%	42,757 Common Stock
Dec 14 2022	SELL Payment of exercise price or tax liability	$97,604 $10.93 p/Share	8,930 Reduced 18.2%	40,132 Common Stock
Dec 14 2022	BUY Exercise of conversion of derivative security	$97,594 $5.04 p/Share	19,364 Added 28.3%	49,062 Common Stock
Nov 16 2022	SELL Open market or private sale	$126,510 $11.88 p/Share	10,649 Reduced 26.39%	29,698 Common Stock
Jul 19 2022	SELL Sale (or disposition) back to the issuer	$7,955 $8.4 p/Share	947 Reduced 2.29%	40,347 Common Stock
Jul 18 2022	BUY Grant, award, or other acquisition	-	3,710 Added 8.83%	38,294 Common Stock
Mar 16 2022	SELL Payment of exercise price or tax liability	$22,069 $7.97 p/Share	2,769 Reduced 7.41%	34,584 Common Stock

Also insider at

CTSO

Cytosorbents Corp Healthcare

Chief Financial Officer

PJM

Peter J Mariani

EVP & Chief Financial Officer

Alachua, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXGN shares.

Notify only if

Value

Insider Trading

Get notified when an Axogen, Inc. insider buys or sells AXGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Axogen, Inc.

Track Activities on AXGN

Account